no desc

What evidence shows in the approach of T2D – Dr. Manuel Cigarruista

Background Vimeo Live Event

About the event

Dr. Manuel Cigarruista, an endocrinologist from Panama, states that early and strict control of HbA1c is the 1st objective in the management of patients with T2D, since it is directly related to long-term cardiovascular and renal protection. To achieve this control, it is necessary to use treatments such as Gliclazide MR which not only offers the best reduction of HbA1c compared to different oral antidiabetic treatments, but also provides important macro and microvascular protection.

SCAC 03/22 DM 039 DIA
Background Vimeo Live Event

Don't miss our next events!

Subscribe to our newsletter to receive invitations to upcoming events

You can unsubscribe at any time by clicking on the link in our emails.
SERVIER CENTRAL AMERICA AND THE CARIBBEAN, S.A.Edificio Dream Plaza, Costa Del Este, Ciudad de Panamá, Panamá+507-301-0227Todo el contenido de este sitio web, es sólo para los profesionales de la salud y un uso interno del evento.
LogoCopyright © 2022 Servier University by SERVIER CENTRO AMÉRICA Y EL CARIBE, S.A.